10003 PRO Current Products (10003)
Multi-center, Non-comparative Study of Primary Total Knee Arthroplasty (TKA) Functional Performance
This post-marketing investigation will evaluate the functional knee performance of Subjects who have undergone primary total knee arthroplasty (TKA). Data from Subjects who receive one of four contemporary knee configurations from different manufacturers will be pooled to establish a contemporary dataset.
The primary objective of this study is to evaluate the functional performance as measured by the activities of daily living (ADL) sub-score of the Knee Osteoarthritis Outcomes Score (KOOS) patient-reported outcome (PRO) questionnaire of primary TKA at minimum one year post-operation. This will be carried out for all four implant configurations. The final endpoint is a 2-year evaluation.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
The study is designed as a prospective, single arm stratified, multi-center investigation.
Approximately 20 study sites, worldwide, will enroll 840 patients (840 knees). Each study site is expected to enroll approximately 42 patients (42 knees). Cohort reallocation is permitted. There will be no control group. Eight hundred forty (840) Subjects will be stratified into 4 subgroups of 210: fixed bearing cruciate retaining (FB CR), fixed bearing posterior stabilized (FB PS), rotating platform cruciate retaining (RP CR), and rotating platform posterior stabilized (RP PS).
Treatment assignment in this study is not randomized. Each site will only enroll patients in one of the four knee configuration sub-groups most commonly used as their standard of care.
Tipo de estudio
Inscripción (Actual)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
New South Wales
-
Hornsby, New South Wales, Australia, 2077
- Hornsby Ku-Ring-Gai Hospital
-
-
South Australia
-
Adelaide, South Australia, Australia, 5000
- Wakefield Orthopedic Clinic
-
-
Western Australia
-
Crawley, Western Australia, Australia, 6009
- Freemantle Hospital
-
Perth, Western Australia, Australia, 6000
- Royal Perth Hospital
-
-
-
-
California
-
Orange, California, Estados Unidos, 92868
- Orthopaedic Specialty Institute
-
San Diego, California, Estados Unidos, 92103
- UCSD Medical Center
-
-
Colorado
-
Fort Collins, Colorado, Estados Unidos, 80525
- Orthopaedic Center of the Rockies
-
-
Florida
-
Jacksonville, Florida, Estados Unidos, 32205
- Heekin Institute for Orthopedic Research
-
-
Kentucky
-
Louisville, Kentucky, Estados Unidos, 40215
- The Arthroplasty Foundation
-
-
Louisiana
-
New Orleans, Louisiana, Estados Unidos, 70112
- Tulane University Hospital and Clinic
-
-
Nevada
-
Las Vegas, Nevada, Estados Unidos, 89128
- Hip and Knee Research of Nevada
-
-
New Hampshire
-
Lebanon, New Hampshire, Estados Unidos, 03756
- Dartmouth Medical School/Dartmouth-Hitchcock Medical Center
-
-
Ohio
-
Columbus, Ohio, Estados Unidos, 43213
- Cardinal Orthopaedic Institute
-
-
Virginia
-
Alexandria, Virginia, Estados Unidos, 22307-9804
- Anderson Orthopaedic Research Institute
-
-
Washington
-
Seattle, Washington, Estados Unidos, 98122-5330
- Swedish Orthopedic Institute
-
-
-
-
-
Auckland, Nueva Zelanda
- Ascot Hospital
-
-
-
-
-
Harlow, Reino Unido, CM20 1QX
- Princess Alexandra Hospital
-
Llandough, Reino Unido, CF64 2XX
- University Hospital Llandough
-
Middlesborough, Reino Unido, TS4 3BW
- James Cook University Hospital
-
York, Reino Unido, YO30 5RA
- Clifton Park NHS Treatment Centre
-
-
Fife
-
Dunfermline, Fife, Reino Unido, KY12 OSU
- Queen Margaret Hospital
-
-
Surrey
-
Guildford, Surrey, Reino Unido, GU2 7XX
- The Royal Surrey County Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- Subject is male or female and between the ages of 22 and 80 years, inclusive.
- Subject was diagnosed with NIDJD.
- Subject is a suitable candidate for cemented primary TKA using the devices described in this CIP with either a resurfaced or non-resurfaced patellae.
- Subject's TKA device was one of the total knee prostheses described under Interventions.
- Subject is currently not bedridden.
- Subject has given voluntary, written informed consent to participate in this clinical investigation, is willing and able to perform all study procedures and follow-up visits and has authorized the transfer of his/her information to DePuy.
- Subject, in the opinion of the Clinical Investigator, is able to understand this clinical investigation and co-operate with investigational procedures.
- Subject must be comfortable with speaking, reading, and understanding questions and providing responses in English.
- The devices specified in this CIP were implanted.
Exclusion Criteria:
- The Subject is a woman who is pregnant or lactating.
- Contralateral knee has already been enrolled in this study.
- Subject had a contralateral amputation.
- Previous partial knee replacement (unicompartmental, bicompartmental or patellofemoral joint replacement), patellectomy, high tibial osteotomy or primary TKA in affected knee.
- Subject is currently experiencing radicular pain from the spine.
- Subject has participated in an IDE/IND clinical investigation with an investigational product in the last three months.
- Subject is currently involved in any personal injury litigation, medical-legal or worker's compensation claims.
- Subject is a known drug or alcohol abuser or has a psychological disorder that could affect their ability to complete patient reported questionnaires.
- Subject was diagnosed with fibromyalgia that is currently being treated with prescription medication.
- Subject has significant neurological or musculoskeletal disorders or disease that may adversely affect gait or weight bearing (e.g. muscular dystrophy, multiple sclerosis, Charcot disease).
- Subject is suffering from inflammatory arthritis (e.g. rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, etc.).
- Subject is not comfortable with speaking, reading, and understanding questions and providing responses in an available translated language for the PROs in the CIP.
- Subject has a medical condition with less than 2 years of life expectancy.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
CR FB
Subjects receiving a Cruciate Retaining Fixed Bearing implant configuration
|
Subjects will receive one of the following total knee implants: PFC Sigma Fixed Bearing (FB) cruciate retaining (CR), posterior stabilized (PS) or Rotating Platform CR or PS devices. LCS Rotating platform or PS devices. Triathlon CR, PS or mobile bearing devices. NexGen CR, LPS, LPS Flex FB PS, LPS Flex Mobile bearing, or LPS Mobile bearing devices. |
|
PS FB
Subjects Receiving a Posterior Stabilized Fixed Bearing implant configuration
|
Subjects will receive one of the following total knee implants: PFC Sigma Fixed Bearing (FB) cruciate retaining (CR), posterior stabilized (PS) or Rotating Platform CR or PS devices. LCS Rotating platform or PS devices. Triathlon CR, PS or mobile bearing devices. NexGen CR, LPS, LPS Flex FB PS, LPS Flex Mobile bearing, or LPS Mobile bearing devices. |
|
CR RP
Subjects receiving a Cruciate Retaining Rotating Platform implant configuration
|
Subjects will receive one of the following total knee implants: PFC Sigma Fixed Bearing (FB) cruciate retaining (CR), posterior stabilized (PS) or Rotating Platform CR or PS devices. LCS Rotating platform or PS devices. Triathlon CR, PS or mobile bearing devices. NexGen CR, LPS, LPS Flex FB PS, LPS Flex Mobile bearing, or LPS Mobile bearing devices. |
|
PS RP
Subjects receiving a Posterior Stabilized Rotating Platform implant configuration
|
Subjects will receive one of the following total knee implants: PFC Sigma Fixed Bearing (FB) cruciate retaining (CR), posterior stabilized (PS) or Rotating Platform CR or PS devices. LCS Rotating platform or PS devices. Triathlon CR, PS or mobile bearing devices. NexGen CR, LPS, LPS Flex FB PS, LPS Flex Mobile bearing, or LPS Mobile bearing devices. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Knee injury and Osteoarthritis Outcome Score (KOOS) activities of daily living (ADL) sub-score
Periodo de tiempo: up to one year
|
The primary endpoint will be measuerd before surgery and out to a minimum of 1 year after surgery.
The KOOS is a patient self-administered questionnaire that consists of 42 questions.
The KOOS consists of 5 subscales; pain, other symptoms, activities of daily living (ADL), sport and recreational function and knee-related quality of life.
Each question has 5 Likert-like response options.
A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale.
|
up to one year
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Evaluate the psychometric properties of PKIP
Periodo de tiempo: Pre-op (-90 to -1 days before surgery), < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
The Pre and Post-Surgical Patient's Knee Implant Performance (PKIP) questionnaire is a patient self-administered questionnaire that consists of 25 questions relating to the patient's awareness of their knee.
Questions include the patient's self-confidence about the current status of their knee performance, stability, and overall satisfaction.
Each question has a 5, 6 or 10 Likert- like response option.
|
Pre-op (-90 to -1 days before surgery), < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
|
Evaluate the longitudinal functional performance of primary TKA
Periodo de tiempo: < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
< 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
|
|
Evaluate Incidence of Anterior Knee Pain
Periodo de tiempo: Pre-op (-90 to -1 days before surgery), < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
Pre-op (-90 to -1 days before surgery), < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
|
|
Evaluate incidence of asymptomatic and symptomatic crepitus
Periodo de tiempo: Pre-op (-90 to -1 days before surgery), < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
Pre-op (-90 to -1 days before surgery), < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
|
|
Evaluate patients functional performance for PS knees, CR knees, FB knees, and RP knees
Periodo de tiempo: < 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
< 1 year (1 to 303 days), minimum 1 year (304 to 668 days), minimum 2 year (669 to 1763 days)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Director de estudio: Ahmad S. Ismail, MS, CCRP, DePuy Orthopaedics
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 10003
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .